# Georgetown Lombardi Comprehensive Cancer Center

Source: https://onco.cc/institutions/georgetown-lombardi/  
OnCo record `georgetown-lombardi` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The only NCI comprehensive cancer centre in Washington, DC, known for breast cancer research including leadership of the CLEOPATRA pertuzumab trial.

## Summary

NCI-designated since 1974, Georgetown Lombardi is Washington's only comprehensive cancer centre and since 2019 has formed a consortium with Hackensack Meridian's John Theurer Cancer Center in New Jersey. Breast cancer has been its signature: Marc Lippman and Robert Clarke built the hormone-receptor and endocrine-resistance programme, and Sandra Swain led CLEOPATRA, which established pertuzumab plus trastuzumab and docetaxel as first-line therapy for HER2-positive metastatic breast cancer. Louis Weiner's antibody immunotherapy laboratory and a cancer-prevention and population-science programme focused on the DC region round out the portfolio. Care is delivered at MedStar Georgetown University Hospital.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- City: Washington, DC, US
- Type: cancer-center
- NCI designation: comprehensive
- Website: https://lombardi.georgetown.edu

## Sources

- Georgetown Lombardi: https://lombardi.georgetown.edu
- PTCOG: particle therapy facilities in operation: https://www.ptcog.site/index.php/facilities-in-operation-public

## Connected records

- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- technologies: [CyberKnife robotic radiosurgery](https://onco.cc/technologies/cyberknife/), [Endocrine therapy (SERMs, AIs, SERDs)](https://onco.cc/technologies/endocrine-therapy/), [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/), [Proton therapy](https://onco.cc/technologies/proton-therapy/), [Proton therapy machines: cyclotrons, synchrotrons and single-room systems](https://onco.cc/technologies/proton-therapy-systems/), [Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS)](https://onco.cc/technologies/radiosurgery-srs/)
- targets: [Estrogen receptor (ERα)](https://onco.cc/targets/estrogen-receptor/), [HER2](https://onco.cc/targets/her2/)
- drugs: [Docetaxel](https://onco.cc/drugs/docetaxel/), [Pertuzumab](https://onco.cc/drugs/pertuzumab/), [Trastuzumab](https://onco.cc/drugs/trastuzumab/)
- trials: [CLEOPATRA](https://onco.cc/trials/cleopatra/)
- people: [Michael B. Atkins](https://onco.cc/people/michael-atkins/), [Sandra M. Swain](https://onco.cc/people/sandra-swain/)
- institutions: [National Cancer Institute (NIH)](https://onco.cc/institutions/nci/)

---
JSON: https://onco.cc/api/v1/entities/georgetown-lombardi.json